GL1X · GenesisL1 explorer

UniProt P0C024

Peroxisomal coenzyme A diphosphatase NUDT7 (P0C024)

Peroxisomal coenzyme A diphosphatase NUDT7 (UniProt P0C024), EC 3.6.1.-: 70 experimental structures and 1 predicted model on GenesisL1, 37 ligands bound, 66 pockets. Binding sites, druggability and experiment against prediction…

UniProt
P0C024
Protein
Peroxisomal coenzyme A diphosphatase NUDT7
EC
3.6.1.-
Experimental structures
70
Predicted models
1
Ligands
37
Pockets
66 · 26 records with a druggable one

Structures

71 records of P0C024 in the MolNFT archive: 70 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
5QGGPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH2G2 (best 0.62)
5QGGPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH2G—
5QGHPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH2D—
5QGIPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAB0V—
5QGIPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAB0V—
5QGJPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH1A2 (best 0.56)
5QGJPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH1A—
5QGKPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH0S2 (best 0.55)
5QGKPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH0S—
5QGLPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH5A2 (best 0.55)
5QGLPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH5A—
5QGMPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH4Y—
5QGNPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH4D2 (best 0.58)
5QGNPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH4D—
5QGOPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH4A2 (best 0.57)
5QGOPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH4A—
5QGPPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH3Y2 (best 0.42)
5QGPPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH3Y—
5QGQPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH3J—
5QGQPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH3J—
5QGRPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH0J—
5QGRPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH0J—
5QGSPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH0D2 (best 0.53)
5QGSPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH0D—
5QGTPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH04—
5QGTPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH04—
5QGUPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH3G—
5QGVPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH3A2 (best 0.54)
5QGVPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH3A—
5QGWPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH2Y2 (best 0.52)
5QGWPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH2Y—
5QGXPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH2J2 (best 0.50)
5QGXPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH2J—
5QGYPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH1Y2 (best 0.54)
5QGYPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH1Y—
5QGZPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH1J2 (best 0.50)
5QGZPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH1J—
5QH0PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH0P2 (best 0.53)
5QH0Pandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH0P—
5QH1PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH5G2 (best 0.53)
5QH1Pandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH5G—
5QH2Pandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH54—
5QH3PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH4G2 (best 0.54)
5QH3Pandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH4G—
5QH4PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH472 (best 0.55)
5QH4Pandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH47—
5QH5PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH3V2 (best 0.53)
5QH5Pandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH3V—
5QH6PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH0M2 (best 0.55)
5QH6Pandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH0M—
5QH7Pandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH0G—
5QH8PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH0A2 (best 0.54)
5QH8Pandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH0A—
5QH9PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAGZY2 (best 0.50)
5QH9Pandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAGZY—
5QHAPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH3D2 (best 0.54)
5QHAPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH3D—
5QHBPanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal…x-ray diffractionAH312 (best 0.51)
5QHBPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH31—
5QHCPandda analysis group deposition of models with modelled events (E.G. bound ligands) -- crystal…x-ray diffractionAH2M—

11 records more on the page itself.

Ligands

  • B0V · 2-methoxy-~{N}-(2,4,6-trimethylphenyl)ethanamide · in 2 records
  • GZY · 1-[(2S)-2-(3-methoxyphenyl)pyrrolidin-1-yl]ethan-1-one · in 2 records
  • H04 · 1-(2-ethoxyphenyl)piperazine · in 2 records
  • H0A · 1-[(2S)-2-(4-methoxyphenyl)-2,3,6,7-tetrahydro-1H-azepin-1-yl]ethan-1-one · in 2 records
  • H0D · N-(4-chlorophenyl)-N'-[(2R)-1-hydroxybutan-2-yl]urea · in 2 records
  • H0J · 5-(pyridin-2-yl)thiophene-2-carbothioamide · in 2 records
  • H0M · 2-(3-hydroxyphenyl)-N-(pyridin-2-yl)acetamide · in 2 records
  • H0P · 2-(3-hydroxyphenyl)-N-(pyridin-3-yl)acetamide · in 2 records
  • H0S · N-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine · in 2 records
  • H17 · 2-{3-[(2R)-1-acryloylpyrrolidin-2-yl]phenyl}-N-(3-chlorophenyl)acetamide · in 2 records
  • H1A · 2-ethyl-N-(2-hydroxyphenyl)butanamide · in 2 records
  • H1G · 2-(4-methoxyphenyl)-N-{5-[2-oxo-2-(3-oxopiperazin-1-yl)ethoxy]pyridin-3-yl}acetamide · in 2 records
  • H1J · N-(3-chlorophenyl)-2-(4-fluorophenyl)acetamide · in 2 records
  • H1P · 1-(4'-fluoro[1,1'-biphenyl]-2-yl)-1,3-dihydro-2H-pyrrol-2-one · in 2 records
  • H1Y · N-(3-chlorophenyl)-2-phenylacetamide · in 2 records
  • H2G · (2S)-1-{[(5-methylthiophen-2-yl)methyl]amino}propan-2-ol · in 2 records
  • H2J · N-(3-chlorophenyl)-2-(4-methoxyphenyl)acetamide · in 2 records
  • H2Y · 2-(4-methoxyphenyl)-N-(pyridin-3-yl)acetamide · in 2 records
  • H31 · 1-(4'-methyl[1,1'-biphenyl]-2-yl)pyrrolidin-2-one · in 2 records
  • H3A · N-(3-chlorophenyl)-2-(3-methoxyphenyl)acetamide · in 2 records
  • H3D · N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl) cyclopentyl]acetamide · in 2 records
  • H3J · 3-methyl-2-[(pyridin-3-yl)oxy]cyclopenta-2,4-dien-1-one · in 2 records
  • H3V · N-(1,2-oxazol-3-yl)-2-phenylacetamide · in 2 records
  • H3Y · (3aR,4S,6R,7R,8aR)-6-phenyloctahydro-1H-3a,7-epiminocyclohepta[c]pyrrol-4-ol · in 2 records
  • H47 · 2-(3-methoxyphenyl)-N-(1,2-oxazol-3-yl)acetamide · in 2 records
  • H4A · (3aR,4R,6R,7R,8aR)-6-phenyloctahydro-1H-3a,7-epiminocyclohepta[c]pyrrol-4-ol · in 2 records
  • H4D · 3-borono-5-{[(thiophen-2-yl)acetyl]amino}benzoic acid · in 2 records
  • H4G · 2-(2,4-difluorophenyl)-N-(pyridin-3-yl)acetamide · in 2 records
  • H5A · 3,4,5-trimethoxybenzoic acid · in 2 records
  • H5D · 2-{3-[(2S)-1-acetylpyrrolidin-2-yl]phenyl}-N-(3-chlorophenyl)acetamide · in 2 records

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.